Fenfluramine Use and Heart Valve Problems
Author Information
Author(s): Dahl Charles F, Allen Marvin R, Urie Paul M, Hopkins Paul N
Primary Institution: Central Utah Clinic, Department of Cardiology
Hypothesis
Is there a link between fenfluramine use and the development of valvular regurgitation requiring surgery?
Conclusion
Fenfluramine use is associated with a high prevalence of valvular regurgitation, particularly in women, and the need for valve surgery is significantly increased.
Supporting Evidence
- 19.6% of women and 11.8% of men had at least mild aortic or moderate mitral regurgitation.
- Valve surgery was performed on 0.66% of the individuals studied.
- Duration of fenfluramine use was strongly predictive of regurgitation severity.
Takeaway
People who took fenfluramine for weight loss often had heart valve problems, especially women, and many needed surgery.
Methodology
An observational study using echocardiography to assess heart valves in fenfluramine users over several years.
Potential Biases
Potential selection bias as only patients referred for echocardiography were included.
Limitations
The study relied on data from a single clinic and may not represent all fenfluramine users.
Participant Demographics
The study included 4825 women and 918 men, with a mean age of 55.6 years for those who underwent surgery.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 1.21–1.39
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website